Summary by Futu AI
CORNING JERRY BIOPHARMACEUTICALS (ALPHAMAB ONCOLOGY) ANNOUNCED ON 7 FEBRUARY 2024 THAT PURSUANT TO SECTION 2.07A OF THE LISTING RULES OF THE STOCK EXCHANGE OF HONG KONG STOCK EXCHANGE LIMITED, THE COMPANY HAS ADOPTED A COMPREHENSIVE ELECTRONIC PUBLICATION OF CORPORATE COMMUNICATIONS, INCLUDING DIRECTORS' REPORTS, ANNUAL ACCOUNTS, AUDIT REPORTS, INTERIM REPORTS, NOTICE OF MEETINGS, AND ABOVE. Municipal documents, circulars and appointment forms, etc. The arrangement, effective from 31 December 2023, aims to expand the paperless listing mechanism. The Company informs non-registered shareholders that all future corporate communications will be made available electronically via the Company's website and disclosable websites in place of printed copies. Non-registered shareholders must complete the return box and reply by post or email to receive printed company newsletters. The Company stresses that non-registered shareholders should provide an email address through their bank, broker, custodian, agent or Hong Kong Central Clearing (Agent) Limited to receive actionable corporate communications.